up home page bottom

French German version Spanish version Italian version

header image

Get health-care reform right for women

Women’s health care is in fact basic health care: annual gynecological exams; pap smears to screen for cervical cancer; breast-cancer screening, and birth control. Unfortunately, in our current health-care system, women are penalized simply because of their anatomy. On average, women of childbearing age pay 68 percent more out-of-pocket for their health care largely because of reproductive-health needs.

Share

Birth Control, From Taboo Subject to Medical Commodity

Forty-five years ago birth control activist were jailed for distributing birth control information and products on college campuses. Today, breezy, informative, well-written articles about birth control options are considered normal fare in college newspapers.

Share

Reproductive Rights as a Civil Right

Then came the great liberator, THE PILL! Women could have a career AND sex and not have to worry about an unplanned pregnancy. This was a big damn deal in the fight for equal pay. Companies used the ‘impeding-mommy’ excuse to deny women promotions. After all, women were only in the workforce ‘temporally’, until like good girls, we got pregnant and stayed home to fulfill our real job— wife and mother.That sounds insane more than 30-years later, but in the 60s and 70s the newspaper want ads were divided into two sections, MEN and WOMEN.

Share

‘Abortion Drug’ Awaits New Political Treatment

With more research, it could offer new treatments for breast cancer, fibroids and endometriosis. But since it’s an abortion drug, since it weathered a congressional investigation two years ago–and since it’s in short supply–researchers have yet to test its full potential. That, says Amy Allina, program director of the Washington-based National Women’s Health Network, is [...]

Share

Too old for the pill?

As middle years near, women may need to rethink contraceptive choices If you’re approaching the middle years of your life, it might be time to review your choice of contraceptives. But don’t be too hasty in putting them away for good. Middle-age women and teenagers have the highest rates of unintended pregnancy and abortion in [...]

Share

Schering-Plough posts 48% drop

Big Pharma Takes Another Hit Schering-Plough Corp., the maker of the Vytorin and Zetia cholesterol pills, said first-quarter profit fell 48 percent, less than analysts expected, on costs for acquiring Organon Biosciences NV. Profit excluding some items was 53 cents a share, beating analysts’ estimates by 15 cents and boosting shares the most in almost [...]

Share

Thromboembolic Events with Ortho Evra Contraceptive Patch

New Data on Thromboembolic Events with Ortho Evra Contraceptive Patch The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who used the birth control patch were at higher risk of developing venous [...]

Share

Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch

IN THE COURTS: New York Times Examines Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch From DAILY WOMEN’S HEALTH POLICY REPORT, [April 8, 2008] The New York Times on Sunday examined Johnson & Johnson’s use of the legal doctrine of preemption to defend against claims that the birth control patch Ortho Evra [...]

Share

What Was Old Is New Again

Women Turning to Natural Methods of Birth Control Young women are turning to old ways to manage fertility cycles. Amanda Zamani of Asheville, N.C., never really liked hormonal birth control and its effects on her body. She had a hard time remembering to take a birth-control pill at the same time every day, and she [...]

Share

Research and Markets: Contraception Market Report 2007

Research and Markets has announced the addition of Contraception Market Report 2007 to their offering. The UK market for contraceptives, as evaluated in this report, comprises four main sectors: hormone-based products; barrier products; intra-uterine device (IUD) products and other methods. Hormone-based products is a publicly funded sector, is the largest sector, having overtaken barrier products, [...]

Share